Integrated profiling reveals transcription factors and histone modifications crucial for gene regulation in plasma cell leukemia.
Key Points
This research aims to elucidate the regulatory role of enhancers and transcription factors in plasma cell leukemia through detailed epigenomic profiling.
Used TOPmentation for histone modification profiling with minimal cell input
Employed chromosome conformation capture to visualize enhancer-promoter interactions
Analyzed CD138+ cells from plasma cell leukemia patient samples
Generated maps of transcription factor occupancy and chromatin states
Compared patient-derived data with established cell line behaviors.
Identified key transcription factors binding to oncogenic enhancers in plasma cell leukemia
Discovered distinct chromatin profiles associated with CCND1 and CCND2 regulation
Observed multiple transcription factors co-binding at enhancer sites
Demonstrated the bivalent state of silent CCND genes in patient samples
Revealed the genomic binding distribution of transcription factors and histone modifications in patient cells.